Brief: Infant Bacterial Therapeutics H1 operating loss widening to SEK 16.1 mln
Aug 19 (Reuters) - Infant Bacterial Therapeutics AB
IBTb.ST :
* H1 net loss 16.3 million Swedish crowns ($1.95 million)
versus loss 9.7 million crowns year ago
* H1 operating loss 16.1 million crowns versus loss 9.7
million crowns year ago
Source text for Eikon: ID:nWkrhr2487
Further company coverage: IBTb.ST
($1 = 8.3569 Swedish crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Infant Bacterial Therapeutics AB
See all newsBrief: Infant Bacterial Therapeutics Gets FDA Request For Type B Pre-BLA Meeting
Brief: Infant Bacterial Therapeutics Q2 Operating Loss Widens To SEK 30.1 Mln
Brief: Infant Bacterial Therapeutics CFO Leaves The Company
Brief: Infant Bacterial Announces Phase III IBP-9414 Study Results
Brief: Infant Bacterial Therapeutics Q4 Operating Loss SEK 20.5 Mln